Robeauté
France - ParisBiotechnology
Focus: Robeauté is a neurosurgical robotics company founded in 2022, developing technology platforms for oncology and neurology applications. The company operates as a micro-cap biotech with 51-200 employees, headquartered in Paris.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Employees
51-200
Total Funding
$28M
Open Jobs
9+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Robeauté?
AI assessmentEarly-stage surgical robotics play with significant technical and commercial risk; best suited for risk-tolerant innovators seeking equity upside and hands-on development work rather than near-term stability.
Why Work Here
- Ground-floor opportunity in neurosurgical robotics, an emerging high-growth segment with significant unmet clinical need in oncology and neurology
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Robeauté
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.